SHARE CAPITAL (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

SCHEDULE OF SHARE CAPITAL

The Company had the following common share transactions for the three months ended March 31, 2023:

	Three months ended March 31, 2023
	# of shares		Amount
Common shares issued for conversion of convertible debt		710,807	$	1,048,573
Common shares issued for compensation		155,898		105,512
Common shares issued for consulting services		15,000		27,735
Common shares issued on conversion of vested prefunded warrants		1,637,049		2,959,108
Total common shares issued		2,518,754	$	4,140,928

The Company had the following common share transactions for the three months ended March 31, 2022:

	Three months ended March 31, 2022
	# of shares		Amount
Common shares issued for consulting services		40,997	$	88,071
Common shares issued for compensation		29,317		97,121
Total common shares issued		70,314	$	185,192

SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

	March 31, 2023		March 31, 2022
Warrants		12,537,969		5,770,262
Options		1,382,629		717,019
Convertible debentures		11,358,526		-
Total anti-dilutive weighted average shares		25,279,124		6,487,281